Lyra Therapeutics, Inc.
Ticker: LYRA
| Insider | Title |
|---|---|
| Advisors Llc Perceptive | Director, 10% or greater ownership |
| Bridge Venture Management V, L.p. North | 10% or greater ownership |
| Bridge Venture Management Vi, L.p. North | 10% or greater ownership |
| Bridge Venture Partners V A Lp North | 10% or greater ownership |
| Bridge Venture Partners V-b Lp North | 10% or greater ownership |
| Bridge Venture Partners Vi L P North | 10% or greater ownership |
| C Ann Merrifield | Director |
| Corinne Noyes | See Remarks |
| Edward T Anderson | Director, 10% or greater ownership |
| Gp, Llc Nbvm | 10% or greater ownership |
| Harlan Waksal | Executive Chair, Director |
| James R Tobin | Director |
| Jason Cavalier | Chief Financial Officer |
| John E Bishop | Chief Technology Officer |
| Joseph Edelman | Director, 10% or greater ownership |
| Konstantin Poukalov | Director |
| Life Sciences Master Fund Ltd Perceptive | 10% or greater ownership |
| Ls (a), Llc Perceptive | 10% or greater ownership |
| Maria Palasis | President CEO, Director |
| Michael Seth Altman | Director |
| Nancy Lynn Md Snyderman | Director |
| Pamela E. Nelson | SVP, Regulatory Affairs |
| Richard A Damore | 10% or greater ownership |
| Richard Nieman | Chief Medical Officer |
| Robert E. Richard | SVP, Technical Operations |
| W Bradford Smith | Director |